Trans fat labeling study
This article was originally published in The Tan Sheet
FDA is seeking comment on a proposed experimental study of trans fat claims on foods, according to a Federal Register notice slated for publication Feb. 6. The study would "evaluate the effect of various possible disclosure requirements intended to help consumers understand and apply trans fat claims they might see on food products," the agency explains. The proposed study would be conducted online among roughly 2,880 adult respondents, FDA states. Data gathered from the study would be used to "assess likely consumer responses to various disclosure requirements for nutrient content claims." The compliance date for FDA's requirement that products containing trans fat be appropriately labeled was Jan. 1 (1"The Tan Sheet" July 14, 2003, p. 7). Comments on the proposal are due by April 7...
You may also be interested in...
Manufacturers of dietary supplements that contain more than .5 g of trans fat will be required to list the amount of the ingredient, as well as the amounts of saturated fat and cholesterol, on the Supplement Facts panel by Jan. 1, 2006
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.